Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
about
The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-AnalysisEmerging candidate biomarkers for Parkinson's disease: a reviewMore than a Rumor Spreads in Parkinson's DiseaseValue of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisDecrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interferenceAn Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with DementiaThe role of biomarkers and imaging in Parkinson's disease.Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility studyCerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directionsNovel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathyCorrelation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseThe diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders.Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's diseaseAbnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patientsIncreased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's diseaseCSF biomarkers cutoffs: the importance of coincident neuropathological diseases.Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.Interaction between pathogenic proteins in neurodegenerative disorders.Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Biomarkers for trials of neuroprotection in Parkinson's disease.Neurobiology of cognitive impairment in Parkinson's disease.Cerebrospinal fluid biomarkers in Parkinson disease.Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review.Recent developments in biomarkers in Parkinson diseaseMolecular biomarkers of neurodegeneration.Biomarker time out.Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.How many biomarkers to discriminate neurodegenerative dementia?
P2860
Q26785974-481E4F9D-045F-49E0-BACE-C1B2A601CC57Q27015018-86B91D7C-0BC9-47E1-9286-7DD1AF70DC8DQ28066571-F626707B-4F90-4C2C-9721-C03A5C7369CBQ28082380-567FF385-9B73-4BCF-B46A-C52424A0FF9BQ28545821-E7387604-F556-495F-B07C-7D440CB59F5BQ28552902-172D77D4-B15D-42EF-B571-3009A650F56FQ31041660-F84C495A-72F8-45AF-9D6D-2F012B1B8074Q31096478-45D8428D-A50A-4D56-A362-A450E7066FFFQ34118169-05F9B9F3-F368-4FC9-88CE-7AE35A2843DAQ34237637-1A7D1E35-8A07-45A1-9350-187D38AF06FDQ34356116-65557C4E-78FF-414F-9D1D-16A010979BB7Q34544824-956043E2-2561-424C-B4AD-5EB7BB0E3276Q34714560-E2582BA1-B61D-4E4F-B1C7-389551E17865Q34806122-3DD91B6C-724A-4BE2-8796-6C66F1AB13A9Q35055373-A75EB5E1-62CC-4D66-AF61-730E82DD8F8AQ35139572-A55820C4-CDE4-4AE0-A56C-8EC84E6C3DD8Q35597118-70DC7E39-2DAB-46D9-8BA2-9109174E2C07Q35897340-4A60F616-EE8F-4A5B-8CAC-D75175565FADQ35969183-54CEA63F-95B9-4CDA-A7A4-2B83BF7A2DE8Q36120659-CA909DDC-B739-479D-AA31-4314B46EA6A8Q36245278-5A30ADE2-66CE-4C73-8A14-275E5A029932Q36551527-20A9E9FD-86F9-4F12-ACA8-CCB4895F69A1Q37225128-18B9E62E-AE20-4BF4-A045-2DFB724075C1Q37272860-54333E1C-45EF-4C9B-AB94-5850B17B83FBQ37345484-2F8F1819-927A-40C4-B41E-ED9C016E70F7Q37969262-2FF23582-5419-423B-A544-36563018C0CFQ38037155-40CE559E-822E-4038-BED6-7585259BC18DQ38038544-381EDD04-B501-44F1-A0D2-DDA4BCF2DC7EQ38067143-6FCB1B28-1DFC-4CE1-9DE6-488B490DBC0DQ38082586-E5B8DED1-54AB-436C-90FB-CEA45B84F27EQ38115735-268D6DA8-F152-42C6-872E-C65B48EE8948Q38119095-66FA40EA-6A0B-4167-9C72-84137D393D95Q38154930-4FF7922C-1EE1-4C97-B727-09132CCC8D0CQ38190038-AAAB08A3-74DC-4759-8A83-AC97DC0CC51FQ38247307-48B6B87A-F1A3-4816-AD5B-BBF882954C4EQ38271572-8CA5800D-2E44-489D-B006-D3E0F1286037Q38289739-068FE32B-F769-40B3-B785-4BBA1EB5E173Q38392505-655272EF-C315-4EA4-8179-FE664E076E28Q38421118-535F5093-59A2-4D95-9EAB-1D1B990EB110Q38570242-4B26AA58-7FBF-4ECC-9CF0-2429686453EF
P2860
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
description
im April 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 April 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2011
@uk
name
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@en
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@nl
type
label
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@en
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@nl
prefLabel
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@en
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Cerebrospinal fluid Tau/α-synu ...... ase and degenerative dementias
@en
P2093
Alessandro Padovani
Aroldo Rossi
Barbara Borroni
Claudia De Carlo
Davide Chiasserini
Gianni Bellomo
Lucilla Parnetti
Mohamed M Qureshi
Mustafa T Ardah
Nicola Tambasco
P2860
P304
P356
10.1002/MDS.23670
P407
P577
2011-04-05T00:00:00Z